Aap Implantate AG Shares Gain Full Market Admission

aap Implantate AG announced that all previously unadmitted shares have gained full admission for trading on the regulated market of the Frankfurt Stock Exchange. The shares, previously identified under ISIN codes DE000A32VP65 and DE000A4096G8, will commence trading under the existing ISIN DE000A3H2101 starting August 4, 2025. This move ensures that all company shares, including those previously subject to lock-up agreements, will be freely tradable from August 5, 2025.

Shareholders do not need to take any action as adjustments will occur automatically through Clearstream Banking and custodian banks. This development marks a significant regulatory milestone for aap Implantate AG, enhancing share liquidity and market access for investors.